258 related articles for article (PubMed ID: 26444494)
1. An LSC epigenetic signature is largely mutation independent and implicates the HOXA cluster in AML pathogenesis.
Jung N; Dai B; Gentles AJ; Majeti R; Feinberg AP
Nat Commun; 2015 Oct; 6():8489. PubMed ID: 26444494
[TBL] [Abstract][Full Text] [Related]
2. Six1 regulates leukemia stem cell maintenance in acute myeloid leukemia.
Chu Y; Chen Y; Li M; Shi D; Wang B; Lian Y; Cheng X; Wang X; Xu M; Cheng T; Shi J; Yuan W
Cancer Sci; 2019 Jul; 110(7):2200-2210. PubMed ID: 31050834
[TBL] [Abstract][Full Text] [Related]
3. Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.
Gentles AJ; Plevritis SK; Majeti R; Alizadeh AA
JAMA; 2010 Dec; 304(24):2706-15. PubMed ID: 21177505
[TBL] [Abstract][Full Text] [Related]
4. Association of a murine leukaemia stem cell gene signature based on nucleostemin promoter activity with prognosis of acute myeloid leukaemia in patients.
Ali MA; Naka K; Yoshida A; Fuse K; Kasada A; Hoshii T; Tadokoro Y; Ueno M; Ohta K; Kobayashi M; Takahashi C; Hirao A
Biochem Biophys Res Commun; 2014 Jul; 450(1):837-43. PubMed ID: 24960197
[TBL] [Abstract][Full Text] [Related]
5. Convergent epigenetic evolution drives relapse in acute myeloid leukemia.
Nuno K; Azizi A; Koehnke T; Lareau C; Ediriwickrema A; Corces MR; Satpathy AT; Majeti R
Elife; 2024 Apr; 13():. PubMed ID: 38647535
[TBL] [Abstract][Full Text] [Related]
6. Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemia.
Dorrance AM; Neviani P; Ferenchak GJ; Huang X; Nicolet D; Maharry KS; Ozer HG; Hoellarbauer P; Khalife J; Hill EB; Yadav M; Bolon BN; Lee RJ; Lee LJ; Croce CM; Garzon R; Caligiuri MA; Bloomfield CD; Marcucci G
Leukemia; 2015 Nov; 29(11):2143-53. PubMed ID: 26055302
[TBL] [Abstract][Full Text] [Related]
7. Promoter DNA methylation and expression levels of HOXA4, HOXA5 and MEIS1 in acute myeloid leukemia.
Musialik E; Bujko M; Kober P; Grygorowicz MA; Libura M; Przestrzelska M; Juszczyński P; Borg K; Florek I; Jakóbczyk M; Siedlecki JA
Mol Med Rep; 2015 May; 11(5):3948-54. PubMed ID: 25585874
[TBL] [Abstract][Full Text] [Related]
8. The rarity of ALDH(+) cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients.
Hoang VT; Buss EC; Wang W; Hoffmann I; Raffel S; Zepeda-Moreno A; Baran N; Wuchter P; Eckstein V; Trumpp A; Jauch A; Ho AD; Lutz C
Int J Cancer; 2015 Aug; 137(3):525-36. PubMed ID: 25545165
[TBL] [Abstract][Full Text] [Related]
9. The Role of the
Chen SL; Qin ZY; Hu F; Wang Y; Dai YJ; Liang Y
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31426381
[TBL] [Abstract][Full Text] [Related]
10. Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells.
Ghasemi R; Struthers H; Wilson ER; Spencer DH
Leukemia; 2021 Feb; 35(2):404-416. PubMed ID: 32398790
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Abnormalities in Acute Myeloid Leukemia and Leukemia Stem Cells.
Xu J; Hang X; Wu B; Chen C; Liu Y
Adv Exp Med Biol; 2019; 1143():173-189. PubMed ID: 31338820
[TBL] [Abstract][Full Text] [Related]
12. Leukemic stem cell phenotype is associated with mutational profile in acute myeloid leukemia.
Han H; Byun JM; Shin DY; Yoon SS; Koh Y; Hong J; Kim I; Lee C; Yoo H; Yun H; Kim MJ; Cho SI; Seong MW; Park SS
Korean J Intern Med; 2021 Mar; 36(2):401-412. PubMed ID: 32811132
[TBL] [Abstract][Full Text] [Related]
13. Role of SIRT1 in the growth and regulation of normal hematopoietic and leukemia stem cells.
Li L; Bhatia R
Curr Opin Hematol; 2015 Jul; 22(4):324-9. PubMed ID: 26049753
[TBL] [Abstract][Full Text] [Related]
14. Exploiting epigenetically mediated changes: Acute myeloid leukemia, leukemia stem cells and the bone marrow microenvironment.
Kogan AA; Lapidus RG; Baer MR; Rassool FV
Adv Cancer Res; 2019; 141():213-253. PubMed ID: 30691684
[TBL] [Abstract][Full Text] [Related]
15. Telomerase inhibition effectively targets mouse and human AML stem cells and delays relapse following chemotherapy.
Bruedigam C; Bagger FO; Heidel FH; Paine Kuhn C; Guignes S; Song A; Austin R; Vu T; Lee E; Riyat S; Moore AS; Lock RB; Bullinger L; Hill GR; Armstrong SA; Williams DA; Lane SW
Cell Stem Cell; 2014 Dec; 15(6):775-90. PubMed ID: 25479751
[TBL] [Abstract][Full Text] [Related]
16. A 17-gene stemness score for rapid determination of risk in acute leukaemia.
Ng SW; Mitchell A; Kennedy JA; Chen WC; McLeod J; Ibrahimova N; Arruda A; Popescu A; Gupta V; Schimmer AD; Schuh AC; Yee KW; Bullinger L; Herold T; Görlich D; Büchner T; Hiddemann W; Berdel WE; Wörmann B; Cheok M; Preudhomme C; Dombret H; Metzeler K; Buske C; Löwenberg B; Valk PJ; Zandstra PW; Minden MD; Dick JE; Wang JC
Nature; 2016 Dec; 540(7633):433-437. PubMed ID: 27926740
[TBL] [Abstract][Full Text] [Related]
17. HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia.
Bartholdy B; Christopeit M; Will B; Mo Y; Barreyro L; Yu Y; Bhagat TD; Okoye-Okafor UC; Todorova TI; Greally JM; Levine RL; Melnick A; Verma A; Steidl U
J Clin Invest; 2014 Mar; 124(3):1158-67. PubMed ID: 24487588
[TBL] [Abstract][Full Text] [Related]
18. Hematopoietic Differentiation Is Required for Initiation of Acute Myeloid Leukemia.
Ye M; Zhang H; Yang H; Koche R; Staber PB; Cusan M; Levantini E; Welner RS; Bach CS; Zhang J; Krivtsov AV; Armstrong SA; Tenen DG
Cell Stem Cell; 2015 Nov; 17(5):611-23. PubMed ID: 26412561
[TBL] [Abstract][Full Text] [Related]
19. BET inhibitors impair leukemic stem cell function only in defined oncogenic subgroups of acute myeloid leukaemias.
Massé A; Roulin L; Pasanisi J; Penneroux J; Gachet S; Delord M; Ali A; Alberdi A; Berrou J; Passet M; Hernandez L; Quentin S; Gardin C; Raffoux E; Adès L; Braun T; Soulier J; Clappier E; Dombret H; Puissant A; Itzykson R
Leuk Res; 2019 Dec; 87():106269. PubMed ID: 31751766
[TBL] [Abstract][Full Text] [Related]
20. CD34⁺/CD38⁻ acute myelogenous leukemia cells aberrantly express CD82 which regulates adhesion and survival of leukemia stem cells.
Nishioka C; Ikezoe T; Furihata M; Yang J; Serada S; Naka T; Nobumoto A; Kataoka S; Tsuda M; Udaka K; Yokoyama A
Int J Cancer; 2013 May; 132(9):2006-19. PubMed ID: 23055153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
